Literature DB >> 24025450

Preclinical Alzheimer's disease criteria.

Anne M Fagan1, Stephanie J B Vos.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24025450      PMCID： PMC4639923          DOI： 10.1016/S1474-4422(13)70222-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  3 in total

1.  Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study.

Authors:  Stephanie Jb Vos; Chengjie Xiong; Pieter Jelle Visser; Mateusz S Jasielec; Jason Hassenstab; Elizabeth A Grant; Nigel J Cairns; John C Morris; David M Holtzman; Anne M Fagan
Journal:  Lancet Neurol       Date:  2013-09-04       Impact factor: 44.182

2.  Do preclinical Alzheimer's disease criteria work?

Authors:  Ronald C Petersen
Journal:  Lancet Neurol       Date:  2013-09-04       Impact factor: 44.182

3.  Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.

Authors:  D S Knopman; C R Jack; H J Wiste; S D Weigand; P Vemuri; V Lowe; K Kantarci; J L Gunter; M L Senjem; R J Ivnik; R O Roberts; B F Boeve; R C Petersen
Journal:  Neurology       Date:  2012-05-02       Impact factor: 9.910
  3 in total
  4 in total

1.  Increased CSF Aβ during the very early phase of cerebral Aβ deposition in mouse models.

Authors:  Luis F Maia; Stephan A Kaeser; Julia Reichwald; Marius Lambert; Ulrike Obermüller; Juliane Schelle; Jörg Odenthal; Peter Martus; Matthias Staufenbiel; Mathias Jucker
Journal:  EMBO Mol Med       Date:  2015-07       Impact factor: 12.137

Review 2.  Ultra-Early Phase pathologies of Alzheimer's disease and other neurodegenerative diseases.

Authors:  Hitoshi Okazawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

Review 3.  Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies.

Authors:  Joana R Guedes; Taotao Lao; Ana L Cardoso; Joseph El Khoury
Journal:  Front Neurol       Date:  2018-08-14       Impact factor: 4.003

4.  Memory markers in the continuum of the Alzheimer's clinical syndrome.

Authors:  Mario A Parra; Clara Calia; Vivek Pattan; Sergio Della Sala
Journal:  Alzheimers Res Ther       Date:  2022-09-30       Impact factor: 8.823
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.